Michael Waters
Emergency Medicine · Chula Vista, CANPI 1801829775
Payments from drug & device makers
Across 4,063 payments — averaging $3264.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$4.9M
- Roche Products Limited$1.3M
- Boehringer Ingelheim International GmbH$1.3M
- Genentech, Inc.$1.2M
- Novavax Inc$524K
- Melinta Therapeutics, LLC$463K
- plus $3.6M from 32 others
Across 20 payments — averaging $1855.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Valneva Austria GmbH$24K
- F. Hoffmann-la Roche AG$7K
- Eli Lilly$6K
- GSK$378
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$13,264,090 in reported general payments places this provider in the 95th percentile of 6,006 emergency medicine providers in California.
Other emergency medicine in Chula Vista
- Jeffrey OvercashChula Vista$31.8M
- Todd SimmonsEscondido$19.9M
- Barry HellerLong Beach$11.5M
- Gregory HachigianSacramento$10.9M
- Masaru OshitaSacramento$7.9M
- Brian BearieSan Bernardino$6.5M
- Julie KasarjianRiverside$4.9M
- Anna Ryabets-LienhardLos Angeles$3M
- Justin YanuckDowney$2.7M
- Michael McCulloughFresno$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.